INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
INDUSTRIALISATION
INDUSTRIALISATION
Patrik Ingvarsson
Nolato Group
NOLATO’S VIRTUAL FACTORY
Patrik Ingvarsson, showcases the Nolato's virtual factory, highlighting the advantages of virtual tools for product development in the medical device industry.
INDUSTRIALISATION
PCI Pharma Services
COMPANY SHOWCASE: PCI PHARMA SERVICES
As a trusted partner, PCI offers expertise and solutions in sterile fill-finish and specialist final assembly and packaging of advanced drug delivery and drug-device combination products, including seamless end-to-end injectable solutions.
SUSTAINABILITY
Philipp Ludihuser
SCHOTT Pharma
PIONEERING PHARMACEUTICAL PACKAGING: A PUSH FOR DECARBONISATION AND CIRCULARITY
Philipp Ludihuser and Arne Kloke highlight how SCHOTT Pharma’s collaboration with customers and partners in the pharmaceutical industry reduces the carbon emissions from the production of vials, cartridges, ampoules and syringes, as well as introducing circular solutions to increase resource efficiency.
INTERVIEW
Glenn Svedberg
Nolato Group
INTERVIEW with GLENN SVEDBERG
Glenn Svedberg engages in a wide-ranging discussion around the role and importance of sustainability in the drug delivery industry, and how Nolato Group has approached implementing this critical aspect of the modern industry landscape. Mr Svedberg considers how sustainability factors play into the relationship between CDMOs like Nolato and pharma companies, the importance of materials and how to drive forward sustainability goals within pharma and drug delivery.
SUSTAINABILITY
David Pircher
Baumann Medical
CREATING VALUE – SUSTAINABLE APPROACHES FOR THE MEDICAL DEVICE INDUSTRY
David Pircher provides insights from a sustainability journey, showcasing what suppliers can contribute and how innovation and partnership support a common vision. The article outlines where the industry stands and why sustainability is a top priority, with concrete examples.
WEARABLES
Dr Greg Moakes
LTS
TRUST THE PROGRESS: INTRODUCING AUTOMATION TO ENHANCE ON-BODY INJECTOR MANUFACTURING
Greg Moakes and Tzach Sadi the process and benefits of automating the production process for its on-body injector device, Sorrel™.
WEARABLES
Dr Andrea Allmendinger
ten23 health
TECHNICAL CHALLENGES DURING THE DEVELOPMENT OF ON-BODY INJECTORS
Andrea Allmendinger, Michael Adler, Carole Delauney and Hanns-Christian Mahler provide an overview of large-volume wearable injection devices for the subcutaneous delivery of biologics and discuss the technical challenges associated with the development and manufacturing of these drug/device combination products.
INDUSTRIALISATION
Lorenzo Vaccarella
Paragon Medical
FUTURE-PROOFING YOUR DRUG DELIVERY DEVICE: CONSIDERATIONS FOR EFFECTIVE DESIGN
Lorenzo Vaccarella highlights six critical areas to consider early in the drug delivery device development journey. He discusses how strategically investing time during the early stages of the design cycle and throughout development can ultimately save both time and cost down the road when the product is being manufactured and deployed into the market.
INDUSTRIALISATION
Lars Keinicke Hansen
Stevanato Group
DELIVERING INTELLIGENT AUTOINJECTOR ASSEMBLY SOLUTIONS FOR COMPLEX CUSTOMER-SPECIFIC REQUIREMENTS
Lars Keinicke Hansen discusses the potential of technology to enhance the efficiency and productivity of manufacturing processes for both pharmaceutical companies and contract development and manufacturing organisations, as well as the skills and expertise required to maximise the potential gains technology can offer.
INDUSTRIALISATION
Michael Wiglenda
Gerresheimer
FROM IDEA TO MASS PRODUCTION: RAPIDLY AND SAFELY INDUSTRIALISING INNOVATIONS
Michael Wiglenda describes Gerresheimer’s approach to the industrialisation of drug delivery devices, using the production of the company’s Gx Inbeneo
®
cartridge-based autoinjector as an example.
INDUSTRIALISATION
Colby Chen
SHL Medical
AUTOMATING HIGH-MIX, LOW-TO-MEDIUM-VOLUME AUTOINJECTOR ASSEMBLY
Colby Chen and Ian Chang discuss how the introduction of modularity can close the gap in traditional assembly systems to enable fully automated, high-quality autoinjector assembly in support of low- volume/high-mix manufacturing.
INDUSTRIALISATION
Ian Thompson
Ypsomed
YPSOMED’S PLATFORM PRODUCT TRANSFORMATION AND APPROACH TO STRATEGIC PARTNER NETWORKING FOR SELF-INJECTION DEVICES
Ian Thompson describes how Ypsomed has transformed the market for platform-based self-injection devices and extended the concept of platform products beyond the core device by developing working practices with strategic networking partners, helping pharma companies and patients to source safe, reliable and easy-to-use drug-device combination products.
INDUSTRIALISATION
Sebastien Cordier
Aptar Pharma
MACHINABILITY OF ETFE-FILM-COATED PREFILLED SYRINGE PLUNGER WITH VENT-TUBE INSERTION
Sebastien Cordier, Benjamin Brocco, Audrey Chardonnet and Edgar Bauer discuss the results of tests on the performance of PremiumCoat
®
syringe plungers on high-speed fill-finish operations with vented insertion.
EXPERT VIEW
Dave Beckstoffer
MATERIAL SELECTION & EFFICIENT DEVELOPMENT PROCESSES FOR WEARABLE INJECTOR DRIVE SYSTEMS
Dave Beckstoffer explains the importance of material selection in drive system development, the key attributes of materials towards a wearable and auto-delivery device, and discusses the need to achieve industrialisation based on material selection and relevant manufacturing processes.
INDUSTRIALISATION
Herman Rusch
IGS GeboJagema
IMPLEMENTING INDUSTRY 4.0: LESSONS LEARNED OVER TWO DECADES
Herman Rusch and Rob van den Brand present four lessons for implementing Industry 4.0 technology and practices in the drug delivery industry, which IGS GeboJagema has learned during its own journey to Industry 4.0 over the past 20 years.
EXPERT VIEW
Andreas Wild
USING EFFICIENT PROOF-OF-CONCEPT TESTS AND PILOT MOULDS FOR DEVICE DEVELOPMENT SUCCESS
Andreas Wild and Andreas Montag discuss the value of early proof-of-concept testing and sample production for drug delivery device development projects, with an emphasis on how partnership and consultation can smooth and enhance this process, including for design for automation and design for manufacturing considerations.
INJECTION
Dr Uwe Rothhaar
SCHOTT Pharma
PACKAGING MATERIAL IDENTIFICATION TO ENSURE SELECTION OF BEST-MATCHING COMPONENTS FOR PARENTERAL DRUGS
Uwe Rothhaar, Daniel Haines, Matthias Bicker and Thomas Schmidt discuss the analytical techniques used to identify the material components and composition of primary containers for injectable drug products.
INJECTION
Olivia Houselander
Owen Mumford
THE CHALLENGES OF DEVELOPING DRUG DELIVERY DEVICES FOR THE JAPANESE MARKET
Olivia Houselander outlines some of the challenges of developing drug delivery devices for the Japanese market and shares details of Owen Mumford’s latest two products to gain approval in Japan.
INJECTION
Manuela Giacon
Stevanato Group
DELIVERING ON GLP-1 DEMAND: A COMBINATION OF DEVICE OFFERINGS AND SUPPLY STRATEGY
Manuela Giacon and Josh Gordon, review the growth in demand for glucagon-like peptide-1 treatments and present Stevanato Group's response to this exciting opportunity, showcasing its Alina
®
device platform for pen injectors and the Aidaptus
®
two-step, single-use autoinjector.
INJECTION
Vetter Pharma
COMPANY SHOWCASE: VETTER PHARMA
Vetter is a CDMO that offers services for pharma and biotech firms of all sizes and locations and holds numerous patents, including technologies for protection against tampering and counterfeiting. Its expertise ranges from lyophilisation (freeze-drying) to siliconisation and more.
INJECTION
Jeff Clement
PCI Pharma Services
ACCELERATING INNOVATION: THE POWER OF PARALLEL DEVELOPMENT FOR AN AUTOINJECTOR LAUNCH
Jeff Clement and Bill Welch explore the essential considerations for navigating the parallel development of a drug product in a vial and a prefilled syringe for an autoinjector, together with the downstream final assembly and pack considerations, from early-phase clinical trials to commercialisation.
EXPERT VIEW
Dan Cowen
ACCELERATING COMBINATION PRODUCT DEVELOPMENT USING DIGITAL TWIN TECHNOLOGY
Dan Cowen, Sebastian White and Anthony Robinson, discuss the value that implementing a digital twin could provide to drug delivery device design across multiple stages of a development programme.
INJECTION
Dr Michael Adler
ten23 health
TRANSITIONING FROM VIAL TO SUBCUTANEOUS INJECTION DEVICES FOR BIOLOGICAL DRUG PRODUCTS
Michael Adler, Venkata Appa Reddy Goli, Andrea Allmendinger and Hanns-Christian Mahler, discuss the various factors that need to be considered when transferring to a delivery device for subcutaneous injection, such as a prefilled syringe or autoinjector, during clinical trials or post-launch, especially when transferring from a vial format for intravenous infusion.
EXPERT VIEW
Dr Timothy Noakes
NAVIGATING THE TRANSITION TO SUSTAINABLE MEDICAL PROPELLANTS
Timothy Noakes, Sheryl Johnson and Richard Greenhough, discuss the status of the current move from high-global-warming-potential propellants for pressurised metered dose inhalers to more sustainable alternatives.
Prev
1
2
3
4
5
6
…
13
Next
Top
